TNF and rheumatoid arthritis: Most participants with RA were on DMARDs (n = 49, 79%), 40% (n = 25) were on TNF inhibitors, 17% (n = 11) were on JAK inhibitors, and 19% (n = 12) were on costimulation inhibitors.